The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 6, 2009, Pages 653-658

  Kariv, Revital ^a   Plesec, Thomas P ^a   Goldblum, John R ^a   Bronner, Mary ^a   Oldenburgh, Mary ^a   Rice, Thomas W ^a   Falk, Gary W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; POSTOPERATIVE PERIOD; PROGNOSIS;

AGED; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 67349108276     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.11.024     Document Type: Article

References (53)

1. Altorki N.K., Sunagawa M., Little A.G., et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 161 (1991) 97-99
2. Pera M., Trastek V.F., Carpenter H.A., et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?. Ann Thorac Surg 54 (1992) 199-204
3. Rice T.W., Falk G.W., Achkar E., et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 11 (1993) 1832-1836
4. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105 (1993) 40-50
5. Edwards M.J., Gable D.R., Lentsch A.B., et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 223 (1996) 585-589
6. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
7. Cameron A.J., and Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92 (1997) 586-591
8. Ferguson M.K., and Naunheim K.S. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 114 (1997) 824-829
9. Collard J.M., Romagnoli R., Hermans B.P., et al. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. Am J Surg 174 (1997) 307-311
10. Falk G.W., Rice T.W., Goldblum J.R., et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 49 (1999) 170-176
11. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 230 (1999) 433-438
12. Patti M.G., Arcerito M., Feo C.V., et al. Barrett's esophagus: a surgical disease. Gastrointest Surg 3 (1999) 397-403
13. Zaninotto G., Parenti A.R., Ruol A., et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 87 (2000) 1102-1105
14. Dar M.S., Goldblum J.R., Rice T.W., et al. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?. Gut 52 (2003) 486-489
15. Romagnoli R., Collard J.M., Gutschow C., et al. Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view. J Am Coll Surg 197 (2003) 365-371
16. Tseng E.E., Wu T.T., Yeo C.J., et al. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome-an update. J Gastrointest Surg 7 (2003) 164-170
17. Reed M.F., Tolis Jr. G., Edil B.H., et al. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79 (2005) 1110-1115
18. Tharavej C., Hagen J.A., Peters J.H., et al. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc 20 (2006) 439-443
19. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
20. Reid B.J., Blount P.L., Feng Z., et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 3089-3096
21. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120 (2001) 1630-1639
22. Reid B.J., Levine D.S., Longton G., et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95 (2000) 1669-1676
23. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
24. Weston A.P., Sharma P., Topalovski M., et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 1888-1893
25. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
26. Wang K.K., Wongkeesong M., and Buttar N.S. American Gastroenterological Association: medical position statement-role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 128 (2005) 1468-1470
27. Wang K.K., Sampliner R.E., and Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797
28. Hirota W.K., Zuckerman M.J., Adler D.G., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 63 (2006) 570-580
29. Tschanz E.R. Do 40% of patients resected for Barrett esophagus with high-grade dysplasia have unsuspected adenocarcinoma?. Arch Pathol Lab Med 129 (2005) 177-180
30. Ruol A., Merigliano S., Baldan N., et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction: comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 10 (1997) 190-195
31. Reid B.J., Haggitt R.C., Rubin C.E., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19 (1988) 166-178
32. Rice T.W., Blackstone E.H., Goldblum J.R., et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 122 (2001) 1077-1090
33. Rice T.W. Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 101 (2006) 2177-2179
34. Konda V.J., Ross A.S., Ferguson M.K., et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?. Clin Gastroenterol Hepatol 6 (2008) 128-129
35. Birkmeyer J.D., Stukel T.A., Siewers A.E., et al. Surgeon volume and operative mortality in the United States. N Engl J Med 349 (2003) 2117-2127
36. Chang L.C., Oelschlager B.K., Quiroga E., et al. Long term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 10 (2006) 341-346
37. Moraca R.J., and Low D.E. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 141 (2006) 545-549
38. Williams V.A., Watson T.J., Herbella F.A., et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 11 (2007) 1589-1597
39. Low D.E., Kunz S., Schembre D., et al. Esophagectomy: it's not just about mortality anymore-standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg 11 (2007) 1395-1402
40. De Boer A.G., Genovesi P.I., Sprangers M.A., et al. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 87 (2000) 1716-1721
41. Headrick J.R., Nichols F.C., Miller D.L., et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 73 (2002) 1697-1702
42. Boyce H.W. Barrett esophagus: endoscopic findings and what to biopsy. J Clin Gastroenterol 36 Suppl 1 (2003) S6-S18
43. Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51 (2002) 671-676
44. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32 (2001) 368-378
45. Downs-Kelly E., Mendelin J.E., Bennett A.E., et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 103 (2008) 2333-2340
46. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65 (2007) 3-10
47. Schembre D.B., Huang J.L., Lin O.S., et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 67 (2008) 595-601
48. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 57 (2008) 1200-1206
49. Shaheen N.J., Sharma P., Overholt B.F., et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia: interim results of the AIM dysplasia trial. Gastroenterology 134 (2008) A-37
50. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40 (2008) 370-379
51. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 40 (2008) 359-369
52. Kara M.A., Peters F.P., Fockens P., et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest Endosc 64 (2006) 176-185
53. Sharma P., Bansal A., Mathur S., et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc 64 (2006) 167-175